ABVC BioPharma, Inc. (ABVC) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for ABVC BioPharma, Inc. (ABVC).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $2.75

Daily Change: -$0.11 / 4.00%

Daily Range: $2.59 - $2.96

Market Cap: $44,491,792

Daily Volume: 383,156

Performance Metrics

1 Week: 9.17%

1 Month: -44.02%

3 Months: 106.3%

6 Months: 445.8%

1 Year: 277.9%

YTD: 344.1%

Company Details

Employees: 19

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is headquartered in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

Selected stocks

Quince Therapeutics, Inc. (QNCX)

FingerMotion, Inc. (FNGR)

Socket Mobile, Inc. (SCKT)